Sign In
Buy JAZZ
$252.86
-5.52 (-2.14%)
At Close: Jul 31, 2026
Did Hedge Funds Make The Right Call On Jazz Pharmaceuticals Plc (JAZZ)?
11:29pm, Saturday, 11'th Jul 2020
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail invest
Zogenix: Market Reaction To Fintepla's Approval Offers A Gift To Investors
01:38pm, Tuesday, 30'th Jun 2020
The weak market on Friday and day traders not getting paid immediately caused Zogenix shares to trade down after FDA approval of Fintepla®. Black box not news.
Nasdaq's $1.2 trln biotech index draws Europe's COVID drug hunters
01:31pm, Tuesday, 30'th Jun 2020
Spain's Pharma Mar is looking at listing on New York's Nasdaq market, joining a flurry of biotech companies aiming to tap investors' voracious appetite for the sector as it tests one of its therapies
BofA Raises Jazz Pharma Estimates After Zepzelca Update
06:19pm, Thursday, 18'th Jun 2020
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) provided encouraging updates on its commercial efforts in a recent conference call on the lung cancer drug Zepzelca, according to BofA Securities.The Jazz Pharm
Jazz's Aggressive Lung Cancer Drug Zepzelca Gets FDA Approval
02:15pm, Tuesday, 16'th Jun 2020
FDA's accelerated approval to Jazz's (JAZZ) Zepzelca as a monotherapy for metastatic small cell lung cancer patients set to boost the company's oncology portfolio.
Jazz Pharmaceuticals (JAZZ) in Focus: Stock Moves 5.6% Higher
12:33pm, Tuesday, 16'th Jun 2020
Jazz Pharmaceuticals (JAZZ) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Jazz Pharma Scores Surprise Early Approval For Lung Cancer Treatment
08:46am, Tuesday, 16'th Jun 2020
Jazz Pharmaceuticals (JAZZ) and partner PharmaMar have announced a surprise early approval from the US FDA for its Zepzelca treatment for adults with metastatic small cell lung cancer (SCLC) with dise
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced along with its partner PharmaMar (MSE: PHM) that the U.S. Food and Drug Administration (FDA) approved Zepzelca™ (lurbinectedin) for the treatm
Jazz Securities Designated Activity Company -- Moody's: Jazz's new exchangeable notes issuance is credit negative
01:26pm, Tuesday, 09'th Jun 2020
Moody's Investors Service commented that Jazz Pharmaceuticals plc's recent increase in debt to add cash to the balance sheet for general corporate purposes is credit negative due to higher financial l
Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 2.000% Exchangeable Senior Notes due 2026
11:00am, Tuesday, 09'th Jun 2020
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ("Jazz Pharmaceuticals") today announced the pricing of $850 million aggregate principal amount of 2.000% exchangeable senior notes due 2026 in a private offeri
Jazz Pharmaceuticals Announces Private Offering of $850 Million of Exchangeable Senior Notes due 2026
11:00am, Monday, 08'th Jun 2020
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Jazz Investments I Limited, its wholly-owned subsidiary (the "Issuer"), intends to offer, subject to market conditions and other factors, $
Hedge Funds Are Warming Up To Jazz Pharmaceuticals Plc (JAZZ)
05:40am, Monday, 08'th Jun 2020
In this article we will take a look at whether hedge funds think Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) is a good investment right now. We check hedge fund and billionaire investor sentiment before de
Hedge Funds Are Warming Up To Jazz Pharmaceuticals Plc (JAZZ)
01:14am, Sunday, 07'th Jun 2020
In this article we will take a look at whether hedge funds think Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) is a good investment right now. We check hedge fund and billionaire investor sentiment before de
Why Is Jazz (JAZZ) Up 4.8% Since Last Earnings Report?
03:31pm, Thursday, 04'th Jun 2020
Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
